- Report
- July 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- April 2025
- 402 Pages
Global
From €5225EUR$5,450USD£4,366GBP
- Report
- March 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- December 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- July 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- July 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- January 2025
- 250 Pages
Global
From €4792EUR$4,999USD£4,004GBP
- Report
- October 2024
- 200 Pages
Global
From €4744EUR$4,949USD£3,964GBP
- Report
- May 2024
- 82 Pages
United States
From €3355EUR$3,500USD£2,804GBP
- Report
- October 2023
- 182 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- February 2024
- 80 Pages
Europe
From €4554EUR$4,750USD£3,805GBP
- Book
- April 2015
- 384 Pages
The Cognitive Function market within the context of Neurology is focused on the development of treatments and therapies for cognitive disorders, such as Alzheimer's disease, dementia, and other neurological conditions. These treatments and therapies are designed to improve cognitive functioning, including memory, attention, language, and executive functioning. The market includes a range of products, including drugs, medical devices, and digital health solutions.
The Cognitive Function market is a rapidly growing sector, with a focus on developing innovative treatments and therapies to improve the quality of life for those affected by neurological conditions. Companies in this market include AbbVie, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
